The data presented is related to the pharmaceutical situation, using Level I
monitoring indicators on structures and processes of the pharmaceutical system from the World Health Organization (WHO), in the 13
Caribbean countries: Antigua and Barbuda, Bahamas, Barbados, Belize, Dominican Republic, Grenada, Guyana, Jamaica, Saint
Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname and Trinidad and Tobago. Given the low number of
respondents, no great significance should be attached to the percentages1 in the report. The Caribbean data are compared with
that for the Americas region (with a total of 31 participating countries) and with data from 2003 (with participation of 9
Caribbean countries), where possible.